Recruiting NA Hemiparetic Stroke

New treatment option for Hemiparetic Stroke

Official title Visual Stimulation Through Video Therapy to Enhance Lower Limb Motor Recovery After Stroke

ClinicalTrials.gov ID: NCT07629674

What this study is testing

What it's testing
This pilot study evaluates video therapy for lower limb motor recovery after stroke, an approach remains insufficiently documented. This single-center pilot study uses a Single-Case Experimental Design (SCED) to evaluate the effects of intensive video therapy combined with conventional rehabilitation in patients with subacute or chronic post-stroke hemiparesis.
  • You might receive a placebo (an inactive treatment) instead of the study drug, decided by chance.

A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.

Who can take part

Ages 18 to 80

You may be able to join if

  • \- First or recurrent hemispheric ischemic or hemorrhagic stroke in the subacute or chronic phase (from 1 month to 1 year post-stroke).
  • Currently receiving rehabilitation care in a Physical Medicine and Rehabilitation (PM\&R) department
  • Able to walk 3 meters back and forth, with or without an assistive device.
  • Provided informed consent, signed jointly with the investigator.

You likely can't join if

  • \- Severe hemispatial neglect.
  • Severe spasticity impairing proper positioning (Modified Ashworth Scale \> 3).
  • Severe general disabling medical conditions.
  • Associated cerebellar syndrome.
  • Major comprehension disorders, psychiatric illness, or cognitive impairments that could interfere with study participation.
  • Participants under full legal guardianship (tutorship).
See the full eligibility criteria
Who can join
  • \- First or recurrent hemispheric ischemic or hemorrhagic stroke in the subacute or chronic phase (from 1 month to 1 year post-stroke).
  • Currently receiving rehabilitation care in a Physical Medicine and Rehabilitation (PM\&R) department
  • Able to walk 3 meters back and forth, with or without an assistive device.
  • Provided informed consent, signed jointly with the investigator.
What rules you out
  • \- Severe hemispatial neglect.
  • Severe spasticity impairing proper positioning (Modified Ashworth Scale \> 3).
  • Severe general disabling medical conditions.
  • Associated cerebellar syndrome.
  • Major comprehension disorders, psychiatric illness, or cognitive impairments that could interfere with study participation.
  • Participants under full legal guardianship (tutorship).
  • Pregnant or breastfeeding women.

The study team makes the final eligibility decision.

Where it's taking place

  • Saint-Etienne, France

Compensation & support

Compensation mentioned.

ClinicalTrials.gov doesn't provide a reliable structured field for payment or travel support - confirm details with the study team.

Questions & answers

Do participants get paid in this trial?

This study's listing includes signals that participants may be compensated or receive a stipend. Amounts vary and are set by the study team - confirm the details with them.

Is it free to join, and do I need insurance?

Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.

How long does this study last?

The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.

Who can join this trial?

This study is enrolling all sexes, 18 years to 80 years. The study team makes the final eligibility decision.

Where is this trial taking place?

Study sites include Saint-Etienne, France. Enter your location above to see the nearest site and check your eligibility.

Explore other conditions

BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.